BioLineRx Ltd. Accounts Payable for the year ending December 31, 2024: USD 5.58 M

BioLineRx Ltd. Accounts Payable is USD 5.58 M for the year ending December 31, 2024, a -48.63% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • BioLineRx Ltd. Accounts Payable for the year ending December 31, 2023 was USD 10.87 M, a 56.03% change year over year.
  • BioLineRx Ltd. Accounts Payable for the year ending December 31, 2022 was USD 6.97 M, a 25.13% change year over year.
  • BioLineRx Ltd. Accounts Payable for the year ending December 31, 2021 was USD 5.57 M, a -5.93% change year over year.
  • BioLineRx Ltd. Accounts Payable for the year ending December 31, 2020 was USD 5.92 M, a -24.07% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities